Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers; inclusion does not imply endorsement by the HBPD INT.

Section editor

Shui-Ying Lei

Email: hbpdje@gmail.com

September

The 7th Chinese conference on oncology & 11th cross-strait academic conference on oncology September 6-9, 2012; Beijing, China

Topics include oncology related pathology, basic research, surgical and internal therapy, radiotherapy, biology therapy, imaging, intervention therapy, nursing, general therapy and treatment for ache. For more information, please contact: Ke Gong, Bin Zhu, Education Center, Beijing Shijitan Hospital, Capital Medical University, 10 Yangfangdian Tieyi Road, Haidian Area, Beijing 100038, China. Tel: 86-10-63926335, or 63926989; Fax: 86-10-63926989; Email:zwh@cco2012.org. Website: http: //www.cco2012.org.

October

17th world congress on advances in oncology and 15th international symposium on molecular medicine October 11-13, 2012; Hotel Creta Maris Resort, Hersonissos, Crete, Greece

The congress is organized by the International Journal of Oncology, Oncology Reports, International Journal of Molecular Medicine, Molecular Medicine Reports, Experimental and Therapeutic Medicine and Oncology Letters. For registration and further information, please contact: Professor D.A. Spandidos, 10 Vriaxidos Street, Athens 11634, Greece. Tel: 30-210-722-7809; Fax: 30-210-725-2922; Email: conference@spandidos-publications. com. Website: http://www.spandidos-publications.com.

30th annual congress of Turkish pediatric surgical association and 16th annual congress of Turkish pediatric surgical nurses association October 17-20, 2012; Ankara, Turkey

The congress will be held with international participation in Ankara/Turkey between October 17-20, 2012 at Sheraton Hotel & Convention Center. It is aiming to supply all participants with the latest academical and technological developments in the field by our national & international invited speakers and sponsors. For more information, please contact: Congress Secretariat, Prof. Dr. Aydin Yagmurlu, Ankara University Pediadric Surgery, eayagmur@medicine.ankara.edu.tr; or Organization, Burak Akicier, BSBMIC, info@bsb.com.tr. Website: http:// english.cocukcerrahisi2012.org/index.php?

The 2nd world congress on controversies in the management of viral hepatitis (C-Hep) October 18-20, 2012; Berlin, Germany

The 2nd C-Hep Congress will be held in Berlin, Germany on October 18-20, 2012. The C-Hep Congress attempts to summarize all the key new data recently presented- and how it might be implemented in routine care of hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in viral hepatitis and benefits not only hepatologists and infectious diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances. The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment. For more information, please visit: Website: http://comtecmed. com/chep/2012/Default.aspx.

20th united European gastroenterology week October 20-24, 2012; Amsterdam, Netherlands

The congress is organized by the United European Gastro-enterology Federation. For more information, please contact: UEGF Secretariat, Wienerbergstr. 11/12A, 1100 Vienna, Austria. Tel: +43-1-997-16-39; Fax: 43-1-997-16-39-10; Email: office@uegf.org. Website: www.uegf.org.

13th Asia-Pacific congress on clinical microbiology and infection October 25-28, 2012; Beijing, China

The congress is hosted by Asia-Pacific Society of Clinical Microbiology and Infection (APSCMI, formerly WPSC). The chairman of this congress is Prof. Lan-Juan Li, Zhejiang University School of Medicine, Hangzhou,China. The congress is to provide the channels to demonstrate and share the progress that all specialists have achieved, link resources in chemotherapy and infectious diseases. For more information, please contact: Congress Secretariat (China), Beijing MedConference Service Co., Ltd., Ms. Xiao-Xue Bian, Room 510, B tower, Free Town Center, No. 58, Dongsanhuan Rd., Chaoyang District, Beijing 100022, China. Tel: 86-10-67122288ext274; Fax: 86-10-67160676; Email: bianxiaoxue@mpco.cn. Website: http://www. apccmi 2012.org/index.html.

November

24th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics November 6-9, 2012; Dublin, Ireland

The 24th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics will take place from November 06-09 2012 at Dublin, Ireland. Hosted by the European Organisation for Research and Treatment of Cancer, the National Cancer Institute and the American Association for Cancer Research, the 2012 symposium will bring together over 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. For more information, please visit: http:// www.ecco-org.eu/Home/Conferences/Conferences/ EORTC_NCI_AACR%202012.aspx.

Post-GWAS Horizons in molecular epidemiology: digging deeper into the environment November 11-14, 2012; Westin Diplomat Resort, Hollywood, FL, USA

Genome-wide association studies (GWAS) have brought forth a vast amount of information on genetic risk factors for cancer. The conference will showcase and discuss new areas of research in molecular epidemiology, focusing on the integration of novel measures of internal and external environmental factors in consortia and genetic studies. Research findings will be presented to illustrate the vast potential within the context of epidemiologic studies in a post-GWAS context to further the prevention of cancer and elucidate mechanisms of carcinogenesis. Large-scale publicly-available research resources will be highlighted and their "rules to play" discussed. Late-breaking findings from genomics, epigenomics, and proteomics in epidemiologic studies will be presented with a view to discern the most promising strategies with the greatest public health impact. For more information, please visit: http:// www.aacr.org/home/scientists/meetings--workshops/ special-conferences/post-gwas-horizons-in-molecularepidemiology.aspx.

Translational cancer research for basic scientists November 26-December 1, 2012; Hilton Boston Back Bay, Boston, MA, USA

This workshop is hosted in close collaboration with the Dana-Farber Cancer Institute/Harvard Cancer Center, comprised of Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health and Massachusetts General Hospital. The Translational Cancer Research for Basic Scientists Workshop will provide basic research scientists with a better understanding of translational research, teach them how to adapt their research for maximum clinical impact, and help them transition into a new career in translational cancer medicine. This innovative workshop addresses many aspects of translational research including leading multidisciplinary teams, working collaboratively and effectively with industry partners, recognizing the unique needs and environment of the clinic and clinical laboratories, dealing with the regulatory and compliance issues in translational science, and understanding the perspective of the patient in order to place research questions into a broader context. During the course of the week, attendees will gain perspective and background knowledge of the disease from translational scientists in academia and industry, clinicians and patients, while learning about the latest methods and approaches in cutting-edge translational cancer research. For further information, please contact Lyngine Calizo, PhD, program administrator, at (215) 446-7265 or lyngine.calizo@aacr.org.

10.1016/S1499-3872(12)60207-0)